Emergency department management of pulmonary embolism

Emergency Medicine Clinics of North America

Volumn 19, Issue 4, 2001, Pages 995-1012

  Edlow, Jonathan A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; DIAGNOSTIC VALUE; DYSPNEA; ECHOCARDIOGRAPHY; EMERGENCY WARD; HUMAN; HYPOTENSION; LUNG EMBOLISM; OXYGEN SATURATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYNCOPE; THORAX PAIN;

EID: 0035195192     PISSN: 07338627     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0733-8627(05)70231-5     Document Type: Review

References (54)

1. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism: The Columbus Investigators
2. The urokinase pulmonary embolism trial: A national cooperative study
3. Thrombolytic therapy of pulmonary embolism: A comprehensive review of current evidence
4. Clinical experience with superior vena caval Greenfield filters
5. Inferior vena caval filters: Review of a 26-year single-center clinical experience
6. Anticoagulant drugs in the treatment of pulmonary embolism: A contolled trial
7. Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis
8. The clinical course of pulmonary embolism
9. Pulmonary embolectomy: A 25-year experience
10. Greenfield filter as primary therapy for deep venous thrombosis and/or pulmonary embolism in patients with cancer
11. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease: Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group
12. Natural history of pulmonary embolism
13. Thrombolytic therapy for pulmonary embolism: Is it effective? Is it safe? When is it indicated?
14. Resolution rate of acute pulmonary embolism in man
15. Pulmonary angiography in experimental pulmonary embolism
16. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis: Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group
17. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism
18. Mechanical fragmentation and pharmacologic thrombolysis in massive pulmonary embolism
19. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism
20. Management of venous thromboembolism
21. Thrombolytic therapy in venous thromboembolism. Clinical trials and current indications
22. Pulmonary embolism
23. Alteplase versus heparin in acute pulmonary embolism: Randomised trial assessing right-ventricular function and pulmonary perfusion
24. Acute pulmonary embolism: Clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)
25. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis: A meta-analysis of randomized, controlled trials
26. Pulmonary embolectomy for acute massive pulmonary embolism: An analysis of 71 cases
27. Long-term experience with transvenous catheter pulmonary embolectomy
28. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction
29. Medical compared with surgical treatment for massive pulmonary embolism
30. Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy
31. Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism
32. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis
33. Streptokinase and heparin versus heparin alone in masstve pulmonary embolism: A randomized controlled trial
34. Thrombolytic therapy for pulmonary embolism. Frequency of intracranial hemorrhage and associated risk factors
35. Management strategies and determinants of outcome in acute major pulmonary embolism: Results of a multicenter registry
36. A new treatment for severe pulmonary embolism: Percutaneous rheolytic thrombectomy
37. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: Results of a multicenter registry
38. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home
39. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis
40. Thrombolytic therapy in acute pulmonary embolism
41. Thrombolytic therapy for venous thromboembolism: Complications and contraindications
42. Pulmonary embolism: Long-term follow-up after treatment with full-dose heparin, streptokinase or embolectomy
43. Treatment of pulmonary embolism with full-dose heparin, streptokinase or embolectomy - Results and indications
44. Pulmonary embolectomy: A 20-year experience at one center
45. Friedrich Trendelenberg and the surgical approach to massive pulmonary embolism
46. The weight-based heparin dosing nomogram compared with a "standard care" nomogram: A randomized controlled trial
47. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism: The THESEE Study Group, Tinzaparine ou Heparine Standard: Evaluations dans I'Embolie Pulmonaire
48. Clinical characteristics of patients with acute pulmonary embolism stratified according to their presenting syndromes
49. Untreated patients with pulmonary embolism. Outcome, clinical, and laboratory assessment
50. Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism
51. Pulmonary embolectomy by catheter device in massive pulmonary embolism
52. The treatment of deep vein thrombosis and pulmonary embolism
53. Physician practices in the treatment of pulmonary embolism and deep venous thrombosis
54. Prognostic significance of right ventricular hypokinesis and perfusion lung scan defects in pulmonary embolism